Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Credit Rating
Announcement under Regulation 30(4) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201505-02-2019
05-02-2019
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Results release & Earnings Call Notice30-01-2019
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Newspaper Publication in respect of Notice regarding Issue of Duplicate Share certificate.18-01-2019
NEULAND LABORATORIES LTD. - 524558 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Neuland Laboratories Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.17-01-2019
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Newspaper Advertisement in relation to Board Meeting to be conducted on February 12, 2019.17-01-2019
NEULAND LABORATORIES LTD. - 524558 - Board Meeting Intimation for To Consider And Take On Record The Un-Audited Financial Results Of The Company For The Quarter Ended December 31, 2018
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019 ,inter alia, to consider and approve To consider and take on record the un-audited financial results of the Company for the quarter ended December 31, 201816-01-2019
Neuland Laboratories Ltd - 524558 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sarada BhamidipatiDesignation :- Company Secretary and Compliance Officer11-01-2019
Neuland Laboratories Ltd - 524558 - Shareholding for the Period Ended December 31, 2018
Neuland Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here03-01-2019
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analysts / Institutional Investor Meet - Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201505-12-2018
Neuland Laboratories receives US FDA approval
Neuland Laboratories on Thursday informed the exchanges that the United States Food and Drug Administration inspected one of its manufacturing facilit29-11-2018